MIM
ARNA

Monashee Investment Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Monashee Investment Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-110,000
Closed -$6.92M – 297
2020
Q2 		$6.92M Buy
+110,000
New +$6.05M 1.04% 22
2018
Q2 		– Sell
-190,000
Closed -$7.5M – 227
2018
Q1 		$7.5M Buy
+190,000
New +$7.39M 2.07% 15

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Monashee Investment Management's ARNA Position: Q3 2020 in Review

Monashee Investment Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2020, closing a stake of 110,000 shares — an estimated $6.92M sold.

Monashee Investment Management first reported a position in ARNA in Q1 2018 and held it in 2 quarters. The position peaked at $7.5M in Q1 2018. 253 funds tracked by Wall St. Rank hold ARNA as of Q3 2020.

  • Monashee Investment Management reported no remaining Arena Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
  • Monashee Investment Management sold 110,000 Arena Pharmaceuticals Inc shares in Q3 2020, an estimated $6.92M.
  • Monashee Investment Management first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 2 quarters.
  • Monashee Investment Management's Arena Pharmaceuticals Inc position peaked at $7.5M in Q1 2018.
  • 253 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2020.

Based on Monashee Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.